Development and validation of a high throughput LC–MS/MS method for simultaneous quantitation of pioglitazone and telmisartan in rat plasma and its application to a pharmacokinetic study

Management of cardiovascular risk factors in diabetes demands special attention due to their co-existence. Pioglitazone (PIO) and telmisartan (TLM) combination can be beneficial in effective control of cardiovascular complication in diabetes. In this research, we developed and validated a high throu...

Descripción completa

Detalles Bibliográficos
Autores principales: Sengupta, Pinaki, Chatterjee, Bappaditya, Mandal, Uttam Kumar, Gorain, Bapi, Pal, Tapan Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Xi'an Jiaotong University 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790748/
https://www.ncbi.nlm.nih.gov/pubmed/29404063
http://dx.doi.org/10.1016/j.jpha.2017.05.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790748/
https://www.ncbi.nlm.nih.gov/pubmed/29404063
http://dx.doi.org/10.1016/j.jpha.2017.05.004

Ejemplares similares